MAIA Biotechnology shareholders re-elect two directors, ratify Grant Thornton at 2026 annual meeting
MAIA Biotechnology, Inc.
Stockholders voted to re-elect Louie Ngar Yee (16.7M for, 8.8M withheld) and Steven Chaouki (25.1M for, 345.7K withheld) as Class I directors for three-year terms.
Ratification of Grant Thornton LLP as independent auditor for FY 2026 passed with 37.3M for, 210K against, 19K abstentions.
Approximately 61.9% of outstanding shares (37.5M of 60.7M) were represented at the meeting, establishing a quorum.
Extracted from this filing and checked against the source text.
Shareholder VotesSEC 8-K Item 5.07confidence 0.95
MAIA Biotechnology, Inc. shareholders approved Ratification of Auditors at the 2026-05-21 meeting.
Proposal
auditor ratification
Outcome
passed
Meeting
2026-05-21
Exact text from the filing
Stockholders ratified the appointment of Grant Thornton LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results were as follows: For Against Abstain 37,278,294 210,408 19,052
MAIA Biotechnology, Inc. shareholders approved Election of Class I Directors at the 2026-05-21 meeting.
Proposal
director election
Outcome
passed
Meeting
2026-05-21
Exact text from the filing
Stockholders re-elected both of the Company’s Class I nominees for director for three-year terms expiring on the annual meeting of stockholders to be held in 2029 or until their successors are duly elected and qualified. Each of the nominees is currently serving as a member of our board of directors. The voting results were as follows: Directors For Withheld Broker Non-Votes Louie Ngar Yee 16,658,677 8,796,832 11,375,414 Steven Chaouki 25,109,811 345,698 11,375,414
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.